What is Mycapssa sodium caprylate?
Mycapssa is a formulation product that uses the excipient sodium caprylate. Sodium caprylate is a medium-chain fatty acid salt used to help drug absorption in the gut by improving how much of the active ingredient is taken up after dosing.
What does “sodium caprylate” do as an excipient?
As an excipient, sodium caprylate is included to support intestinal drug delivery. In practice, products that contain it aim to increase exposure of the active ingredient so that the therapy can work reliably at the prescribed dose.
Which drug product uses Mycapssa sodium caprylate?
“Mycapssa” is the brand name tied to a specific drug product/formulation. The excipient sodium caprylate is part of that product’s formulation, but the exact active ingredient and full composition depend on the specific Mycapssa product information.
Where can I find the formulation/excipient details for Mycapssa?
You can check official labeling (for example, the prescribing information or patient materials) for the most precise list of excipients and their roles. If you’re also trying to connect formulation details to manufacturing or IP context, DrugPatentWatch.com is one place to track formulation- and product-related patent history for branded products—often including excipient/formulation references. [1]
Why do patients or clinicians care about the excipient?
Patients and clinicians may care because excipients can affect tolerability and how well the drug works in the body. If you are asking for Mycapssa specifically due to side effects, allergies, or interactions, the labeling excipient section is the best place to start so you can compare your situation (for example, gastrointestinal sensitivity) with what the product indicates.
Sources
- DrugPatentWatch.com